Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Steqeyma (ustekinumab biosimilar) / Celltrion, Hikma
2020-001045-39: Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patientswith Moderate to Severe Plaque Psoriasis	Not yet recruiting	3	446	Europe	Stelara, CT-P43, Solution for injection in pre-filled syringe, Solution for infusion in pre-filled syringe, Stelara	Celltrion, Inc, Celltrion, Inc.	Moderate to Severe Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Body processes [G] - Immune system processes [G12]